Nashawi M - Search Results

1

The systemic implication of novel non-statin therapies in cardiovascular diabetology: PCSK9 as a case model.

Nashawi M, Sheikh O, Mir M, Te T, Chilton R. Nashawi M, et al. Cardiovasc Endocrinol Metab. 2020 May 5;9(4):143-152. doi: 10.1097/XCE.0000000000000204. eCollection 2020 Dec. Cardiovasc Endocrinol Metab. 2020. PMID: 33225229 Free PMC article. Review.

2

A focused review of cardiovascular guideline related recommendations for the primary care physician in the USA.

Sheikh O, Nashawi M, Battisha A, Chilton R. Sheikh O, et al. Among authors: nashawi m. Cardiovasc Endocrinol Metab. 2020 May 15;9(2):36-41. doi: 10.1097/XCE.0000000000000192. eCollection 2020 Jun. Cardiovasc Endocrinol Metab. 2020. PMID: 32537563 Free PMC article. Review.

3

Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: insights into preservation of sight and looking beyond.

Lahoti S, Nashawi M, Sheikh O, Massop D, Mir M, Chilton R. Lahoti S, et al. Among authors: nashawi m. Cardiovasc Endocrinol Metab. 2020 May 18;10(1):3-13. doi: 10.1097/XCE.0000000000000209. eCollection 2021 Mar. Cardiovasc Endocrinol Metab. 2020. PMID: 33634250 Free PMC article. Review.

4

Cardiorenal protection with SGLT2: Lessons from the cardiovascular outcome trials.

Silva-Cardoso J, Sheikh O, Nashawi M, Pham S, Gallegos KM, Dinkha LR, Chilton RJ. Silva-Cardoso J, et al. Among authors: nashawi m. J Diabetes. 2020 Apr;12(4):279-293. doi: 10.1111/1753-0407.13007. Epub 2019 Dec 11. J Diabetes. 2020. PMID: 31688975 Review.

5

Beyond the myocardium? SGLT2 inhibitors target peripheral components of reduced oxygen flux in the diabetic patient with heart failure with preserved ejection fraction.

Nashawi M, Sheikh O, Battisha A, Mir M, Chilton R. Nashawi M, et al. Heart Fail Rev. 2022 Jan;27(1):219-234. doi: 10.1007/s10741-020-09996-y. Heart Fail Rev. 2022. PMID: 32583230 Review.

6

Neural tone and cardio-renal outcomes in patients with type 2 diabetes mellitus: a review of the literature with a focus on SGLT2 inhibitors.

Nashawi M, Sheikh O, Battisha A, Ghali A, Chilton R. Nashawi M, et al. Heart Fail Rev. 2021 May;26(3):643-652. doi: 10.1007/s10741-020-10046-w. Epub 2020 Nov 9. Heart Fail Rev. 2021. PMID: 33169337 Review.

7

Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy.

Nashawi M, Ahmed MS, Amin T, Abualfoul M, Chilton R. Nashawi M, et al. World J Cardiol. 2021 Dec 26;13(12):676-694. doi: 10.4330/wjc.v13.i12.676. World J Cardiol. 2021. PMID: 35070111 Free PMC article. Review.

8

ST Elevation Myocardial Infarction as Presenting Feature of C-ANCA Vasculitis: A Case of a Diagnostic Dilemma.

Museedi AS, Nashawi M, Ghali A, Hussein AA, Saca J. Museedi AS, et al. Among authors: nashawi m. Eur J Case Rep Intern Med. 2020 May 26;7(8):001658. doi: 10.12890/2020_001658. eCollection 2020. Eur J Case Rep Intern Med. 2020. PMID: 32789132 Free PMC article.

9

Acute inflammatory presentation of orbital metastasis from urothelial carcinoma: a case report.

Ghali A, Bahr T, Sherwani A, Nashawi M, Wilde D, Woolf S. Ghali A, et al. Among authors: nashawi m. Orbit. 2022 Dec;41(6):786-790. doi: 10.1080/01676830.2021.1933082. Epub 2021 Jun 2. Orbit. 2022. PMID: 34078220

10

Cases and etiologies of suspected COVID-19 reactivation.

Ghali A, Rico-Mesa JS, Nashawi M, Cadena J. Ghali A, et al. Among authors: nashawi m. Qatar Med J. 2020 Oct 13;2020(2):26. doi: 10.5339/qmj.2020.26. eCollection 2020. Qatar Med J. 2020. PMID: 33282710 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters